论文部分内容阅读
目的 :探讨有创机械通气 (IMV)在肺性脑病 (肺脑 )综合救治中的价值。方法 :收集我院内科ICU收治的 80例肺脑患者临床资料 ,依是否接受IMV治疗将患者分为IMV组 ( 6 0例 )与非IMV组 ( 2 0例 ) ,χ2 与t检验分析各种相关因素对治疗效果和预后的影响。结果 :IMV组与非IMV组比较 ,两组年龄、病程、营养状况、平均住院天数无显著差异 (P >0 .0 5 ) ,但IMV组APACHEⅡ评分与意识障碍均较非IMV组重 (P <0 .0 5 ) ,CO2 潴留纠正时间明显少于非IMV组 (P <0 .0 0 1) ,而意识障碍缓解时间二组无显著差异 (P >0 .0 5 ) ;两组病死率无显著差异 (P >0 .0 5 ) ,但非IMV组因呼吸衰竭死亡患者明显多于IMV组 (P <0 .0 0 1)。结论 :IMV是抢救肺脑及时有效的重要措施之一。
Objective: To investigate the value of invasive mechanical ventilation (IMV) in the treatment of pulmonary encephalopathy (pulmonary and brain). Methods: The clinical data of 80 patients with pulmonary-brain disease admitted to our hospital were collected and divided into IMV group (60 cases) and non-IMV group (20 cases) according to whether receiving IMV treatment. The impact of related factors on the treatment effect and prognosis. Results: Compared with non-IMV group, there was no significant difference in age, course of disease, nutritional status and average length of hospital stay between IMV group and non-IMV group (P> 0.05), but APACHEⅡscore and disturbance of consciousness in IMV group were significantly higher than those in non-IMV group <0. 05), the time to correct CO2 retention was significantly less than that of non-IMV group (P <0.01), while the time to consciousness impairment was no significant difference between the two groups (P> 0.05) (P> 0.05). However, the deaths from respiratory failure in non-IMV group were significantly more than those in IMV group (P <0.01). Conclusion: IMV is one of the important measures to save lung and brain effectively in time.